FRUMENTO, GIULIA
FRUMENTO, GIULIA
100006 - Dipartimento di Farmacia
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction
2023-01-01 Raffaele, S.; Bonifacino, T.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli., M.
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation
2023-01-01 Raffaele, Stefano; Nguyen, Nhung; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Mannella, Francesca C.; Lambertsen, Kate L.; Madsen, Kirsten; Schroeder, Henrik D.; Hejbøl, Eva K.; Bonanno, Giambattista; Abbracchio, Maria P.; Bonifacino, Tiziana; Fumagalli, Marta
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex.
2021-01-01 Sala, N.; Paoli, C.; Bonifacino, T.; Mingardi, J.; Schiavon, E.; La Via, L.; Milanese, M.; Tornese, P.; Datusalia, A. K.; Rosa, J.; Facchinetti, R.; Frumento, G.; Carini, G.; Salerno Scarzella, F.; Forti, L.; Barbon, A.; Bonanno, G.; Popoli, M.; Musazzi, L.
Effects of the in-vivo treatment with the non-selective GPR17 antagonist montelukast on disease outcome in the SOD1G93A mouse model of ALS
2023-01-01 Bonifacino, T.; Nhung Nguyen, T. P.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M.
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS
2021-01-01 Milanese, M.; Torazza, C.; Provenzano, F.; Bonifacino, T.; Ravera, S.; Balbi, M.; Frumento, G.; Kumar, M.; Cerminara, M.; Puliti, A.; Usai, C.; Bonanno, G.
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
2022-01-01 Bonifacino, T.; Nguyen, T. P. N.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M.
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity
2023-01-01 Bonifacino, Tiziana; Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Marta, Boccazzi; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria Pia, ; Marta, Fumagalli
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis
2022-01-01 Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria, Pia; Bonifacino, Tiziana; Fumagalli, Marta
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction | 1-gen-2023 | Raffaele, S.; Bonifacino, T.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli., M. | |
| A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation | 1-gen-2023 | Raffaele, Stefano; Nguyen, Nhung; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Mannella, Francesca C.; Lambertsen, Kate L.; Madsen, Kirsten; Schroeder, Henrik D.; Hejbøl, Eva K.; Bonanno, Giambattista; Abbracchio, Maria P.; Bonifacino, Tiziana; Fumagalli, Marta | |
| Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex. | 1-gen-2021 | Sala, N.; Paoli, C.; Bonifacino, T.; Mingardi, J.; Schiavon, E.; La Via, L.; Milanese, M.; Tornese, P.; Datusalia, A. K.; Rosa, J.; Facchinetti, R.; Frumento, G.; Carini, G.; Salerno Scarzella, F.; Forti, L.; Barbon, A.; Bonanno, G.; Popoli, M.; Musazzi, L. | |
| Effects of the in-vivo treatment with the non-selective GPR17 antagonist montelukast on disease outcome in the SOD1G93A mouse model of ALS | 1-gen-2023 | Bonifacino, T.; Nhung Nguyen, T. P.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M. | |
| In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS | 1-gen-2021 | Milanese, M.; Torazza, C.; Provenzano, F.; Bonifacino, T.; Ravera, S.; Balbi, M.; Frumento, G.; Kumar, M.; Cerminara, M.; Puliti, A.; Usai, C.; Bonanno, G. | |
| In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis | 1-gen-2022 | Bonifacino, T.; Nguyen, T. P. N.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M. | |
| Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity | 1-gen-2023 | Bonifacino, Tiziana; Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Marta, Boccazzi; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria Pia, ; Marta, Fumagalli | |
| Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis | 1-gen-2022 | Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria, Pia; Bonifacino, Tiziana; Fumagalli, Marta |